Else Nutrition Holdings Inc (OTCQX:BABYF, TSX-V:BABY). has announced that it will be expanding its reach into the Western US and mountain regions with its new listing in all 19 Harmon’s Grocery locations.
Based out of Utah, Harmons is a leader in the grocery space in Utah, with its upscale, family-oriented approach and Harmon’s Grocery is one of the few remaining locally-owned and operated grocery chains in Utah.
READ: Else Nutrition completes full-scale commercial trial manufacturing run of ready-to-drink liquid version of its Plant-Based Complete Nutrition for Toddlers and Kids
“Partnering with Harmon’s fills a strategic distribution gap for us,” said Hamutal Yitzhak, CEO and co-founder of Else Nutrition in a statement.
“It serves as a geographic bridge between our presence in California and Nevada, to the presence we have in Colorado. We’re also delighted by this retailer’s keen attention to quality and health-oriented products,” she added.
Else is expected to hit Harmons shelves in September 2021.
Else Nutrition is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula.
The company - formerly INDI - won the '2017 Best Health and Diet Solutions' award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon.
Else's Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
Contact the author at jon.hopkins@proactiveinvestors.com